Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial

Published:2019-07 Issue:7 Volume:7 Page:594-604
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Sitbon Olivier,Bosch Jaume,Cottreel Emmanuelle,Csonka Denes,de Groote Pascal,Hoeper Marius M,Kim Nick H,Martin Nicolas,Savale Laurent,Krowka Michael

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference27 articles.

1. Incidence and prevalence of pulmonary arterial hypertension in Germany;Hoeper;Int J Cardiol,2016

2. Pulmonary arterial hypertension in France: results from a national registry;Humbert;Am J Respir Crit Care Med,2006

3. An epidemiological study of pulmonary arterial hypertension;Peacock;Eur Respir J,2007

4. International primary pulmonary hypertension study;Abenhaim;Br Heart J,1994

5. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland;Ling;Am J Respir Crit Care Med,2012

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes of upfront combination therapy for portopulmonary hypertension;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

2. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

3. Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

4. Pulmonary Complications of Portal Hypertension;Clinics in Liver Disease;2024-08

5. Comparative Effectiveness of Sotatercept and Approved Add-On Pulmonary Arterial Hypertension Therapies: A Systematic Review and Network Meta-Analysis;Annals of the American Thoracic Society;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3